Pharmacokinetics of ABT-335 and Rosuvastatin in Subjects With Normal Renal Function and Renal Impairment.

Trial Profile

Pharmacokinetics of ABT-335 and Rosuvastatin in Subjects With Normal Renal Function and Renal Impairment.

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Sep 2012

At a glance

  • Drugs Choline fenofibrate; Rosuvastatin
  • Indications Dyslipidaemias
  • Focus Pharmacokinetics
  • Sponsors AstraZeneca
  • Most Recent Events

    • 21 Mar 2012 Additional lead trial investigator (Maureen Kelly) identified as reported by ClinicalTrials.gov.
    • 21 Mar 2012 Official title amended as reported by ClinicalTrials.gov.
    • 26 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top